This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vairo, G.
Right arrow Articles by Adams, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vairo, G.
Right arrow Articles by Adams, J. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2000, p. 4745-4753, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Bcl-2 Retards Cell Cycle Entry through p27Kip1, pRB Relative p130, and Altered E2F Regulation

Gino Vairo,1,dagger Timothy J. Soos,2 Todd M. Upton,3 Juan Zalvide,3 James A. DeCaprio,3 Mark E. Ewen,3 Andrew Koff,2 and Jerry M. Adams1,*

The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia1; Memorial Sloan-Kettering Cancer Center, New York, New York 100212; and Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 021153

Received 28 December 1999/Returned for modification 24 February 2000/Accepted 13 April 2000

Independent of its antiapoptotic function, Bcl-2 can, through an undetermined mechanism, retard entry into the cell cycle. Cell cycle progression requires the phosphorylation by cyclin-dependent kinases (Cdks) of retinoblastoma protein (pRB) family members to free E2F transcription factors. We have explored whether retarded cycle entry is mediated by the Cdk inhibitor p27 or the pRB family. In quiescent fibroblasts, enforced Bcl-2 expression elevated levels of both p27 and the pRB relative p130. Bcl-2 still slowed G1 progression in cells deficient in pRB but not in those lacking p27 or p130. Hence, pRB is not required, but both p27 and p130 are essential mediators. The ability of p130 to form repressive complexes with E2F4 is implicated, because the retardation by Bcl-2 was accentuated by coexpressed E2F4. A plausible relevant target of p130/E2F4 is the E2F1 gene, because Bcl-2 expression delayed E2F1 accumulation during G1 progression and overexpression of E2F1 overrode the Bcl-2 inhibition. Hence, Bcl-2 appears to retard cell cycle entry by increasing p27 and p130 levels and maintaining repressive complexes of p130 with E2F4, perhaps to delay E2F1 expression.


* Corresponding author. Mailing address: C/- The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia. Phone: 61 3 9345 2555. Fax: 61 3 9347 0852. E-mail: adams{at}wehi.edu.au.

dagger Present address: ExGenix Operations Ltd, Richmond, Victoria 3121, Australia.


Molecular and Cellular Biology, July 2000, p. 4745-4753, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zunino, S. J., Storms, D. H. (2009). Resveratrol Alters Proliferative Responses and Apoptosis in Human Activated B Lymphocytes in Vitro. J. Nutr. 139: 1603-1608 [Abstract] [Full Text]  
  • Janumyan, Y., Cui, Q., Yan, L., Sansam, C. G., Valentin, M., Yang, E. (2008). G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation. J. Biol. Chem. 283: 34108-34120 [Abstract] [Full Text]  
  • Wang, L., Pal, S., Sif, S. (2008). Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells. Mol. Cell. Biol. 28: 6262-6277 [Abstract] [Full Text]  
  • Blais, A., van Oevelen, C. J.C., Margueron, R., Acosta-Alvear, D., Dynlacht, B. D. (2007). Retinoblastoma tumor suppressor protein dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. JCB 179: 1399-1412 [Abstract] [Full Text]  
  • Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T. K., Cochran, R., DeMartino, S., Schechtman, K. B., Hussain, I., Holtzman, M. J., Castro, M., and the NHLBI Severe Asthma Research Program (SARP, (2007). Epithelial Cell Proliferation Contributes to Airway Remodeling in Severe Asthma. Am. J. Respir. Crit. Care Med. 176: 138-145 [Abstract] [Full Text]  
  • Pandyra, A. A., Berg, R., Vincent, M., Koropatnick, J. (2007). Combination Silencer RNA (siRNA) Targeting Bcl-2 Antagonizes siRNA against Thymidylate Synthase in Human Tumor Cell Lines. J. Pharmacol. Exp. Ther. 322: 123-132 [Abstract] [Full Text]  
  • Vorburger, S. A., Hetrakul, N., Xia, W., Wilson-Heiner, M., Mirza, N., Pollock, R. E., Feig, B., Swisher, S. G., Hunt, K. K. (2005). Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Molecular Cancer Therapeutics 4: 1710-1716 [Abstract] [Full Text]  
  • Takeuchi, O., Fisher, J., Suh, H., Harada, H., Malynn, B. A., Korsmeyer, S. J. (2005). Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc. Natl. Acad. Sci. USA 102: 11272-11277 [Abstract] [Full Text]  
  • Bai, L., Ni, H.-M., Chen, X., DiFrancesca, D., Yin, X.-M. (2005). Deletion of Bid Impedes Cell Proliferation and Hepatic Carcinogenesis. Am. J. Pathol. 166: 1523-1532 [Abstract] [Full Text]  
  • Mayorga, M., Bahi, N., Ballester, M., Comella, J. X., Sanchis, D. (2004). Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death. J. Biol. Chem. 279: 34882-34889 [Abstract] [Full Text]  
  • Orelio, C., Harvey, K. N., Miles, C., Oostendorp, R. A. J., van der Horn, K., Dzierzak, E. (2004). The role of apoptosis in the development of AGM hematopoietic stem cells revealed by Bcl-2 overexpression. Blood 103: 4084-4092 [Abstract] [Full Text]  
  • Crescenzi, E., Varriale, L., Iovino, M., Chiaviello, A., Veneziani, B. M., Palumbo, G. (2004). Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Molecular Cancer Therapeutics 3: 537-544 [Abstract] [Full Text]  
  • Qiu, L.-Q., Sinniah, R., I-Hong Hsu, S. (2004). Downregulation of Bcl-2 by Podocytes Is Associated with Progressive Glomerular Injury and Clinical Indices of Poor Renal Prognosis in Human IgA Nephropathy. J. Am. Soc. Nephrol. 15: 79-90 [Abstract] [Full Text]  
  • Yan, W., Huang, J.-X., Lax, A.-S., Pelliniemi, L., Salminen, E., Poutanen, M., Toppari, J. (2003). Overexpression of Bcl-w in the Testis Disrupts Spermatogenesis: Revelation of a Role of BCL-W in Male Germ Cell Cycle Control. Mol. Endocrinol. 17: 1868-1879 [Abstract] [Full Text]  
  • Mazzocca, A., Giusti, S., Hamilton, A. D., Sebti, S. M., Pantaleo, P., Carloni, V. (2003). Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines. Mol. Pharmacol. 63: 159-166 [Abstract] [Full Text]  
  • Vantieghem, A., Xu, Y., Assefa, Z., Piette, J., Vandenheede, J. R., Merlevede, W., de Witte, P. A. M., Agostinis, P. (2002). Phosphorylation of Bcl-2 in G2/M Phase-arrested Cells following Photodynamic Therapy with Hypericin Involves a CDK1-mediated Signal and Delays the Onset of Apoptosis. J. Biol. Chem. 277: 37718-37731 [Abstract] [Full Text]  
  • Korbonits, M., Chahal, H. S., Kaltsas, G., Jordan, S., Urmanova, Y., Khalimova, Z., Harris, P. E., Farrell, W. E., Claret, F.-X., Grossman, A. B. (2002). Expression of Phosphorylated p27Kip1 Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors. J. Clin. Endocrinol. Metab. 87: 2635-2643 [Abstract] [Full Text]  
  • Pierce, R. H., Vail, M. E., Ralph, L., Campbell, J. S., Fausto, N. (2002). Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci. Am. J. Pathol. 160: 1555-1560 [Abstract] [Full Text]  
  • Limana, F., Urbanek, K., Chimenti, S., Quaini, F., Leri, A., Kajstura, J., Nadal-Ginard, B., Izumo, S., Anversa, P. (2002). bcl-2 overexpression promotes myocyte proliferation. Proc. Natl. Acad. Sci. USA 99: 6257-6262 [Abstract] [Full Text]  
  • Mao, Y.-W., Xiang, H., Wang, J., Korsmeyer, S., Reddan, J., Li, D. W.-C. (2001). Human bcl-2 Gene Attenuates the Ability of Rabbit Lens Epithelial Cells against H2O2-induced Apoptosis through Down-regulation of the alpha B-crystallin Gene. J. Biol. Chem. 276: 43435-43445 [Abstract] [Full Text]  
  • Gomez-Manzano, C., Mitlianga, P., Fueyo, J., Lee, H.-Y., Hu, M., Spurgers, K. B., Glass, T. L., Koul, D., Liu, T.-J., McDonnell, T. J., Yung, W. K. A. (2001). Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2. Cancer Res. 61: 6693-6697 [Abstract] [Full Text]  
  • Barata, J. T., Cardoso, A. A., Nadler, L. M., Boussiotis, V. A. (2001). Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1. Blood 98: 1524-1531 [Abstract] [Full Text]  
  • Knudson, C. M., Johnson, G. M., Lin, Y., Korsmeyer, S. J. (2001). Bax Accelerates Tumorigenesis in p53-deficient Mice. Cancer Res. 61: 659-665 [Abstract] [Full Text]